UBTF通过PD-L1调节促进急性髓性白血病的发展和免疫逃脱
Chunxia Yang1, Junzhao Wan2, Yan Wang3
1School of Clinical Medicine, Guizhou Medical University, Guiyang 550004, GuiZhou, China; Department of Pediatrics, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, GuiZhou, China.
International immunopharmacology
|March 13, 2025
概括
该研究发现,UBTF在急性髓性白血病 (AML) 中过度表达,与预后不佳和通过PD-L1.1免疫逃避相关. UBTF为AML免疫治疗提供了一个潜在的生物标志物和治疗标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 目前尚不清楚UBTF在急性髓性白血病 (AML) 发病过程中的作用.
- UBTF与各种癌症有关,这表明它具有更广泛的致癌功能.
研究的目的:
- 研究UBTF在AML中的生物功能和预后意义.
- 探索UBTF表达,免疫透和AML的临床结果之间的关系.
- 确定UBTF作为AML免疫治疗的潜在治疗点.
主要方法:
- 使用TCGA和TARGET数据库进行表达形状和临床数据.
- 使用CIBERSORT分析了免疫细胞透,并通过LASSO Cox和多变Cox回归构建了一个预后模型.
- 进行了实验验证,包括细胞系操纵,转录组测序,CD8+ T细胞杀死试验和体内研究.
主要成果:
- 与正常组织相比,UBTF在AML组织中显著过度表达.
- 高UBTF表达与AML患者的临床预后不佳相关.
- UBTF过度表达与增加PD-L1 (CD274) 表达和增强免疫细胞透有关,这表明免疫逃避.
结论:
- UBTF在AML的进展中起着至关重要的作用,可能是通过PD-L1介导的免疫逃避.
- UBTF作为AML的一个有价值的预后生物标志物.
- 准UBTF可能为AML治疗提供一种新的免疫治疗策略.
相关概念视频
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


